Prospecting for drugs in the microbiome: The microbiome is an important source of natural products that can profoundly influence health and disease in the host. Sugimoto et al. constructed a modular, probabilistic strategy called MetaBGC to uncover biosynthetic gene clusters (BGCs) in human microbiome samples (see the Perspective by Henke and Clardy). The authors found geographic and strain-specific distributions of BGCs. By zeroing in on two type II aromatic polyketides, the native organisms were identified, the BGCs were reconstructed in Streptomyces , and the products were characterized. When expressed in Bacillus subtilis , the products resembled currently used anticancer drugs and antibiotics. These polyketides were not cytotoxic but had inhibitory activity against oral Gram-positive bacteria, which may reflect the niche and ecology of the originating organisms. Science , this issue p. eaax9176 ; see also p. 1309
17 October 2022 in Journal of the American Chemical Society
Toxin–antitoxin (TA) systems interfere with essential cellular processes and are implicated in bacterial lifestyle adaptations such as persistence and the biofilm formation. Here, we present structural, biochemical, and functional data on an uncharacterized TA system, the COG5654–COG5642 pair. Bioinformatic analysis showed that this TA pair is found in 2,942 of the 16,286 distinct bacterial species in the RefSeq database. We solved a structure of the toxin bound to a fragment of the antitoxin to 1.50 Å. This structure suggested that the toxin is a mono-ADP-ribosyltransferase (mART). The toxin specifically modifies phosphoribosyl pyrophosphate synthetase (Prs), an essential enzyme in nucleotide biosynthesis conserved in all organisms. We propose renaming the toxin ParT for Prs ADP-ribosylating toxin and ParS for the cognate antitoxin. ParT is a unique example of an intracellular protein mART in bacteria and is the smallest known mART. This work demonstrates that TA systems can induce bacteriostasis through interference with nucleotide biosynthesis.
10 June 2025 in Journal of the American Chemical Society
The determination of incorrect structures for the ABC transporter MsbA gave rise to questions of how this could have occurred. Methodological aspects of the MsbA structure determination are explored in light of this error.